Patent US3529732A successfully refreshed from Google Patents.
US4331652A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Controlled release parasitic formulations and method
Assignee: Eli Lilly and Co
•
Filing: 1980-12-24
•
Granted: 1982-05-25
•
Expires: 2000-12-24
Abstract
Abstract Controlled release formulations useful in controlling endoparasitic infestation in animals over a prolonged period of time are comprised of an anthelmintic agent intimately dispersed throughout a copolymeric matrix derived from the condensation of about 60 to about 95 weight percent of lactic acid and about 40 to about 5 weight percent of glycolic acid, said copolymeric matrix being substantially free of polymerization catalyst.
Inventors
- 👤 Nelson H. Ludwig
- 👤 Rudolph J. Boisvenue
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 18:29
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0068; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2031; A61K9/204; C; C07; C07H; C07H19/00; C07H19/01
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
106 words
A controlled release biodegradable dosage form useful in the prolonged therapeutic and prophylactic control of endoparasites in domestic animals comprising about 20 to about 80 percent by weight of a anthelmintic agent initimately dispersed throughout about 80 to 20 percent by weight of a copolymeric matrix derived from the condensation of about 60 to about 95 weight percent of lactic acid and about 40 to about 5 weight percent of glycolic acid, said copolymer having an inherent viscosity of about 0.08 to about 0.30 when measured in chloroform, and a molecular weight of about 6000 to about 35000, said copolymer being substantially free of polymerization catalyst.
Claim 2
Dependent Claim
106 words
A controlled release biodegradable dosage form useful in the prolonged therapeutic and prophylactic control of endoparasites in domestic animals comprising about 20 to about 80 percent by weight of a anthelmintic agent initimately dispersed throughout about 80 to 20 percent by weight of a copolymeric matrix derived from the condensation of about 60 to about 95 weight percent of lactic acid and about 40 to about 5 weight percent of glycolic acid, said copolymer having an inherent viscosity of about 0.08 to about 0.30 when measured in chloroform, and a molecular weight of about 6000 to about 35000, said copolymer being substantially free of polymerization catalyst.
Claim 3
Dependent Claim
57 words
The formulation of claim 1 wherein the anthelmintic agent is present in the amount of about 30 to about 70 percent by weight, and the copolymer matrix is derived from about 60 to about 90 percent lactric acid and about 40 to about 10 percent glycolic acid, with an inherent viscosity of about 0.10 to about 0.25.
Claim 4
Dependent Claim
55 words
The formulation of claim 2 wherein the copolymeric matrix is derived from about 70 to about 80 percent by weight of lactic acid and about 30 to about 20 percent by weight of glycolic acid, with an inherent viscosity of about 0.13 to about 0.23 and a molecular weight of about 15000 to about 30000.
Claim 5
Dependent Claim
37 words
The formulation of claim 1 wherein the anthelmintic agent is a benzimidazole of the formula ##STR2## wherein: R 7 is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, benzoyl, halobenzoyl, phenylthio, phenylsulfinyl, cyclopropylmethylsulfinyl, and lower alkyl--CO 2 NH--.
Claim 6
Dependent Claim
10 words
The formulation of claim 4 wherein R 7 is phenylthio.
Claim 7
Independent Claim
128 words
A method of controlled prolonged treatment of domestic animals suffering from endoparasitic infestation and in need of treatment or suspected of being susceptible to endoparasitic infestation comprising administering an effective dose of a controlled release anthelmintic formulation which is comprised of about 20 to about 80 percent by weight of an anthelmintic agent intimately dispersed throughout about 80 to about 20 percent by weight of a copolymeric matrix derived from the condensation of about 60 to about 95 weight percent of lactic acid and about 40 to about 5 weight percent of glycolic acid, said copolymer having an inherent viscosity of about 0.08 to about 0.30 when measured in chloroform, and a molecular weight of about 6000 to about 35000, said copolymer being substantially free of polymerization catalyst.
Claim 8
Independent Claim
128 words
A method of controlled prolonged treatment of domestic animals suffering from endoparasitic infestation and in need of treatment or suspected of being susceptible to endoparasitic infestation comprising administering an effective dose of a controlled release anthelmintic formulation which is comprised of about 20 to about 80 percent by weight of an anthelmintic agent intimately dispersed throughout about 80 to about 20 percent by weight of a copolymeric matrix derived from the condensation of about 60 to about 95 weight percent of lactic acid and about 40 to about 5 weight percent of glycolic acid, said copolymer having an inherent viscosity of about 0.08 to about 0.30 when measured in chloroform, and a molecular weight of about 6000 to about 35000, said copolymer being substantially free of polymerization catalyst.
Claim 9
Dependent Claim
73 words
The method of claim 6 wherein the anthelmintic formulation comprises about 30 to about 70 percent by weight of a anthelmintic agent intimately dispersed throughout a copolymer which is derived from about 70 to about 80 weight percent of lactic acid and about 30 to about 20 weight percent of glycolic acid, said copolymer having a viscosity of about 0.13 to about 0.23 and a molecular weight of about 15000 to about 30000.
Claim 10
Dependent Claim
37 words
The method of claim 6 wherein the anthelmintic agent is a benzimidazole of the formula ##STR3## wherein: R 7 is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, benzoyl, halobenzoyl, phenylthio, phenylsulfonyl, cyclopropylmethylsulfinyl, and lower alkyl--CO 2 NH--.
Claim 11
Dependent Claim
10 words
The method of claim 8 wherein R 7 is phenylthio.
References Cited (Backward Citations)
US3056724A
Cited
US3535419A
Cited
US3507952A
Cited
US3887699A
Cited
US3773919A
Cited
US3736646A
Cited
US3991766A
Cited
US3976071A
Cited
US4076798A
Cited
US4144317A
Cited
US3972999A
Cited
US4011312A
Cited
US4118470A
Cited
US4166800A
Cited
US4159322A
Cited
US4166107A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-05-24 | 1985-11-23 | 1986-05-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-05-24 | 1989-11-23 | 1990-05-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-05-24 | 1993-11-23 | 1994-05-25 | $7700.00 | Window Closed / Lapsed |